V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196863 | 20125322 | 1.73 | 66.8 | Curative (C) | 2019-02-04 | 2019-02-06 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 100475408 |
| 20196866 | 20125323 | 1.75 | 97.5 | null | 2019-08-01 | 2019-08-29 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100331604 |
| 20196867 | 20125324 | 1.8 | 91.8 | null | 2016-12-24 | 2017-01-18 | Trastuzumab | 02 | Y | TRASTUZUMAB | 101137947 |
| 20196870 | 20125325 | 1.57 | 72.2 | Palliative (P) | 2018-03-10 | 2018-03-17 | CETUXIMAB | N | N | CETUXIMAB | 100678375 |
| 20196873 | 20125326 | 1.88 | 95.4 | Palliative (P) | 2019-11-28 | 2019-12-05 | CETUXIMAB | 02 | N | CETUXIMAB | 100152753 |
| 20196874 | 20125327 | 1.73 | 124 | Curative (C) | 2016-11-20 | 2017-06-19 | Trastuzumab | 02 | N | TRASTUZUMAB | 100435828 |
| 20196875 | 20125328 | 0 | 75 | Curative (C) | 2020-05-13 | 2020-06-10 | CETUXIMAB | 02 | Y | CETUXIMAB | 100574647 |
| 20196876 | 20125329 | 1.58 | 48 | Palliative (P) | 2017-12-09 | 2017-12-09 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101518905 |
| 20196878 | 20125330 | 1.59 | null | Curative (C) | 2019-12-07 | 2019-12-19 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 101746026 |
| 20196881 | 20125331 | 1.6 | 50 | Palliative (P) | 2020-07-21 | 2020-08-07 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100860788 |
| 20196884 | 20125332 | 1.64 | 49.8 | Palliative (P) | 2019-10-03 | 2019-10-23 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100666472 |
| 20196885 | 20125333 | 1.92 | 50.5 | Curative (C) | 2017-04-18 | 2017-05-08 | Trastuzumab | 02 | null | TRASTUZUMAB | 100913683 |
| 20196890 | 20125334 | 1.8 | 106 | Palliative (P) | 2020-09-22 | 2020-09-23 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100204778 |
| 20196901 | 20125335 | 1.56 | 83.7 | Curative (C) | 2016-08-07 | 2016-08-14 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101496174 |
| 20196902 | 20125336 | 1.77 | 100 | null | 2018-05-29 | 2018-05-31 | CETUXIMAB | 02 | N | CETUXIMAB | 100652039 |
| 20196905 | 20125337 | 1.75 | 75 | null | 2019-09-09 | 2019-10-24 | CETUXIMAB | 02 | N | CETUXIMAB | 101348297 |
| 20196913 | 20125338 | 1.73 | 62 | Adjuvant (A) | null | 2016-10-03 | CETUXIMAB | 02 | null | CETUXIMAB | 101424578 |
| 20196919 | 20125339 | 1.85 | 72 | Neo-adjuvant (N) | 2015-03-23 | 2016-04-08 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101666184 |
| 20196921 | 20125340 | 1.74 | 85.4 | Palliative (P) | 2021-03-09 | 2021-04-05 | CETUXIMAB | 02 | N | CETUXIMAB | 101184257 |
| 20196922 | 20125341 | 1.45 | 73.8 | null | 2015-08-01 | 2015-08-06 | CETUXIMAB | N | null | CETUXIMAB | 100859930 |
| 20196927 | 20125342 | 1.63 | 110 | Neo-adjuvant (N) | 2018-10-02 | 2018-10-21 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101819281 |
| 20196929 | 20125343 | 1.5 | 56.9 | 03 | 2019-01-01 | 2019-02-19 | Capecitabine + Cisplatin + RT | 99 | Y | CAPECITABINE + CISPLATIN | 100103581 |
| 20196930 | 20125344 | 1.71 | 38 | Palliative (P) | 2017-01-14 | 2017-03-12 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100790336 |
| 20196931 | 20125345 | 1.59 | 102 | Curative (C) | 2019-11-23 | 2019-12-01 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101682139 |
| 20196933 | 20125346 | 1.66 | 59.8 | Curative (C) | 2019-06-26 | 2019-06-26 | CETUXIMAB | N | null | TRASTUZUMAB | 101693589 |
| 20196934 | 20125347 | 1.8 | 79 | Palliative (P) | 2016-09-15 | 2018-12-17 | CETUXIMAB | 02 | N | CETUXIMAB | 101665273 |
| 20196936 | 20125348 | 1.77 | 75.35 | Palliative (P) | 2018-08-24 | 2018-08-26 | CETUXIMAB | 02 | N | CETUXIMAB | 100865196 |
| 20196939 | 20125349 | 1.65 | 64 | Neo-adjuvant (N) | 2019-06-06 | 2019-09-01 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100284574 |
| 20196949 | 20125350 | 1.8 | 90.9 | null | 2019-02-27 | 2019-02-27 | Trastuzumab 21 day loading dose | 02 | Y | TRASTUZUMAB | 100954116 |
| 20196952 | 20125351 | 1.58 | 95.4 | null | 2016-05-05 | 2016-05-31 | CETUXIMAB | 02 | N | CETUXIMAB | 100728802 |
| 20196958 | 20125352 | null | null | Palliative (P) | 2016-05-21 | 2016-06-04 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101149968 |
| 20196969 | 20125353 | 1.8 | 117 | null | null | 2018-12-15 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100956813 |
| 20196974 | 20125354 | 1.53 | 71.3 | Palliative (P) | 2017-10-31 | 2017-12-23 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101660556 |
| 20196981 | 20125355 | 1.8 | 88.2 | Curative (C) | 2019-11-25 | 2019-12-03 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101321677 |
| 20196984 | 20125356 | 1.54 | 49 | Palliative (P) | 2019-11-01 | 2020-02-28 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101291757 |
| 20196986 | 20125357 | 1.77 | 71.1 | Palliative (P) | 2017-07-22 | 2017-07-29 | CETUXIMAB | 02 | N | CETUXIMAB | 101543527 |
| 20196991 | 20125358 | 1.84 | 87.2 | Palliative (P) | 2019-03-03 | 2019-03-19 | CETUXIMAB | N | N | CETUXIMAB | 100810515 |
| 20196994 | 20125359 | 1.83 | 93.8 | Palliative (P) | 2016-07-19 | 2017-01-03 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101158263 |
| 20196998 | 20125360 | 1.58 | 100.2 | Curative (C) | null | 2017-05-25 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 100899020 |
| 20196999 | 20125361 | 1.76 | 76 | Curative (C) | 2018-09-24 | 2018-10-07 | Cetuximab 14 day | null | null | CETUXIMAB | 100466039 |
| 20197002 | 20125362 | 1.55 | 65.1 | 03 | 2016-09-26 | 2016-12-28 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 100771478 |
| 20197003 | 20125363 | 1.83 | 92 | Curative (C) | 2018-07-26 | 2018-08-01 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 101280654 |
| 20197006 | 20125364 | 1.71 | 121.95 | Palliative (P) | 2015-06-01 | 2016-07-21 | CETUXIMAB | 02 | N | CETUXIMAB | 101361866 |
| 20197009 | 20125365 | 1.63 | 97 | Palliative (P) | 2018-03-13 | 2018-03-13 | CETUXIMAB | N | N | CAPECITABINE + CISPLATIN | 101382570 |
| 20197011 | 20125366 | 1.81 | 48.1 | Palliative (P) | 2013-03-07 | 2016-04-09 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 101835877 |
| 20197017 | 20125367 | 0 | 49.8 | Neo-adjuvant (N) | 2017-02-12 | 2017-02-13 | Trastuzumab 21 day maintenance | 99 | N | TRASTUZUMAB | 100380943 |
| 20197023 | 20125368 | 1.64 | 69 | Curative (C) | 2019-08-04 | 2019-09-30 | Trastuzumab | 02 | N | TRASTUZUMAB | 100129886 |
| 20197031 | 20125369 | 1.8 | 63.7 | null | 2019-02-06 | 2019-02-07 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 101337046 |
| 20197032 | 20125370 | 1.73 | 92.6 | Curative (C) | 2017-02-17 | 2017-09-29 | Capecitabine + Cisplatin | 2 | N | CAPECITABINE + CISPLATIN | 100167045 |
| 20197037 | 20125371 | 1.62 | 79 | Curative (C) | 2019-01-02 | 2019-04-26 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100412728 |